CA Stock MarketDetailed Quotes
DMT Small Pharma Inc
- 0.000
- 0.0000.00%
15min DelayMarket Closed Jan 10 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00052wk High0.00%Turnover Ratio335.77MShares0.00052wk Low-0.07EPS TTM0Float Cap0.000Historical High0.00P/E (Static)335.77MShs Float0.000Historical Low-0.07EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
Small Pharma Inc Key Stats
Quarterly+Annual
YOY
| (Q1)May 31, 2023 | (FY)Feb 28, 2023 | (Q4)Feb 28, 2023 | (Q3)Nov 30, 2022 | (Q2)Aug 31, 2022 | (Q1)May 31, 2022 | (FY)Feb 28, 2022 | (Q4)Feb 28, 2022 | (Q3)Nov 30, 2021 | (Q2)Aug 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -0.56%5.75M | 37.59%24.7M | -22.04%4.27M | 54.50%7.13M | 64.71%7.46M | 73.49%5.78M | 215.03%17.95M | 140.16%5.47M | 213.42%4.62M | 282.91%4.53M |
| Selling and administrative expenses | -14.01%2.73M | 5.12%10.99M | -79.43%686.89K | 18.59%3M | 78.01%4.1M | 15.44%3.18M | 203.97%10.45M | 94.27%3.34M | 301.05%2.53M | 335.06%2.3M |
| -General and administrative expense | -14.01%2.73M | 5.12%10.99M | -79.43%686.89K | 18.59%3M | 78.01%4.1M | 39.72%3.18M | 203.97%10.45M | 94.27%3.34M | 301.05%2.53M | 335.06%2.3M |
| Research and development costs | 19.41%2.49M | 135.75%11.38M | 90.45%2.9M | 243.11%3.62M | 54.00%2.72M | 334.02%2.09M | 151.42%4.83M | 361.37%1.52M | 37.93%1.06M | 183.11%1.77M |
| Depreciation amortization depletion | 1,404.15%85.53K | 136.46%48.44K | 480.36%31.36K | 9.88%5.74K | 14.23%5.65K | 15.78%5.69K | 233.54%20.49K | 31.24%5.4K | 158.21%5.22K | --4.94K |
| -Depreciation and amortization | 1,404.15%85.53K | 136.46%48.44K | 480.36%31.36K | 9.88%5.74K | 14.23%5.65K | 15.78%5.69K | 233.54%20.49K | 31.24%5.4K | 158.21%5.22K | --4.94K |
| Other operating expenses | -14.33%431.04K | -13.91%2.28M | 7.17%646.21K | -50.99%502.3K | 39.35%630.5K | 462.81%503.16K | 694.68%2.65M | 168.26%602.96K | 1,280.36%1.02M | 1,465.53%452.47K |
| Operating profit | 0.56%-5.75M | -37.59%-24.7M | 22.04%-4.27M | -54.50%-7.13M | -64.71%-7.46M | -73.49%-5.78M | -219.38%-17.95M | -140.19%-5.47M | -213.42%-4.62M | -294.24%-4.53M |
| Net non-operating interest income (expenses) | 2,596.64%105.82K | 104.85%21.02K | -68.48%10.31K | 2.56K | 12,163.89%4.34K | 100.84%3.92K | 10.55%-433.73K | 108.20%32.72K | 0 | 99.65%-36 |
| Non-operating interest income | 2,790.75%113.43K | --21.02K | --10.31K | --2.56K | --4.34K | --3.92K | ---- | ---- | --0 | ---- |
| Non-operating interest expense | --7.62K | --0 | --0 | --0 | --0 | --0 | -10.55%433.73K | -108.20%-32.72K | --0 | -99.65%36 |
| Other net income (expenses) | 45.74%-4.31K | 99.09%-41.34K | 54.14%-2.79K | -85.86%-28.13K | 32.00%-2.53K | 99.82%-7.94K | -391.50%-4.53M | 99.28%-6.08K | 74.84%-15.14K | 74.45%-3.73K |
| Gain on sale of security | 45.74%-4.31K | 98.05%-41.34K | 54.14%-2.79K | -85.86%-28.13K | 32.00%-2.53K | 99.62%-7.94K | -129.24%-2.12M | 99.28%-6.08K | 74.84%-15.14K | 74.45%-3.73K |
| Special income (charges) | ---- | --0 | --0 | --0 | --0 | ---- | ---2.42M | --0 | --0 | --0 |
| -Less:Restructuring and mergern&acquisition | ---- | --0 | --0 | --0 | --0 | ---- | --2.42M | --0 | --0 | --0 |
| Income before tax | 2.39%-5.64M | -7.86%-24.72M | 21.80%-4.26M | -54.55%-7.16M | -64.53%-7.46M | 30.44%-5.78M | -226.11%-22.92M | -54.48%-5.44M | -187.83%-4.63M | -286.24%-4.53M |
| Income tax | 0 | -187.74%-1.89M | -187.74%-1.89M | 0 | 0 | 0 | -9,845.14%-655.17K | -3,448,342.11%-655.17K | 0 | 0 |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 2.39%-5.64M | -2.56%-22.84M | 50.46%-2.37M | -54.55%-7.16M | -64.53%-7.46M | 30.44%-5.78M | -216.49%-22.27M | -35.89%-4.79M | -186.64%-4.63M | -286.24%-4.53M |
| Net income continuous operations | 2.39%-5.64M | -2.56%-22.84M | 50.46%-2.37M | -54.55%-7.16M | -64.53%-7.46M | 30.44%-5.78M | -216.49%-22.27M | -35.89%-4.79M | -186.64%-4.63M | -286.24%-4.53M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 2.39%-5.64M | -2.56%-22.84M | 50.46%-2.37M | -54.55%-7.16M | -64.53%-7.46M | 30.44%-5.78M | -216.49%-22.27M | -35.89%-4.79M | -186.64%-4.63M | -286.24%-4.53M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 2.39%-5.64M | -2.56%-22.84M | 50.46%-2.37M | -54.55%-7.16M | -64.53%-7.46M | 30.44%-5.78M | -216.49%-22.27M | -35.89%-4.79M | -186.64%-4.63M | -286.24%-4.53M |
| Diluted earnings per share | 0.00%-0.02 | 0.00%-0.07 | 0.00%-0.01 | 0.00%-0.02 | -100.00%-0.02 | 33.33%-0.02 | -215.22%-0.07 | 10.12%-0.01 | -292.23%-0.02 | -169.98%-0.01 |
| Basic earnings per share | 0.00%-0.02 | 0.00%-0.07 | 0.00%-0.01 | 0.00%-0.02 | -100.00%-0.02 | 33.33%-0.02 | -215.22%-0.07 | 10.12%-0.01 | -292.23%-0.02 | -169.98%-0.01 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Price
% Chg
No Data